The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1185
June 21, 2004
View Complete Issue         Table of Contents 2019 
Topical Sertaconazole (Ertaczo) -- Another Azole for Tinea Pedis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Topical Sertaconazole (Ertaczo) -- Another Azole for Tinea Pedis
June 21, 2004 (Issue: 1185)
Sertaconazole nitrate (Ertaczo - OrthoNeutrogena), an imidazole antifungal similar to clotrimazole and miconazole, has been approved by the FDA as a 2% cream for topical treatment of interdigital tinea pedis infection. It has been available in Europe...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Topical Sertaconazole (Ertaczo) -- Another Azole for Tinea Pedis
Article code: 1185b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.